Patients receiving antimalarial therapy, specifically hydroxychloroquine, for dif ferent periods were evaluated using contrast sensitivity test (CST) and results were compared with those of electro-retinography (EOG), and pattern visual evokea potential (PVEP), and a matching age control group. The results indicated CST to be most sensitive of the evaluated techniques particularly in patients under 40 years old.
Clinicians are making every possible effort to achieve early diagnosis of chloroquine reti nopathy which is particularly important in the early stages of this condition, when there is still a possibility for reversal.
With the recently increasing use of chloro quine and chloroquine derivatives in the treat ment of connective tissue diseases,I.2 early diagnosis of chloroquine maculopathy has become imperative. In an attempt to achieve this, many tests have been proposed, includ ing visual fields, colour vision, Amsler grid, and fluorescein angiography. 3 , 4 ,5,6,7 Electro-oculography (EO G) is one of these tests, and has been reported to be a sensitive test,S although this is still controversial. 9 The test is still used in several centres for the detec tion of functional disturbances induced by the storage of chloroquines in the retinal pigment epithelium. 10 The spatial contrast sensitivity test (CST), using sinusoidal gratings, is frequently recom mended as a sensitive means of detecting and evaluating several macular diseases.ll, 1 2 The pattern visual evoked potential (PVEP) has also been suggested for testing macular disorders. 1 3 .1 4 We report the results and relative sen sitivity of the CST, EOG and PVEP tests in revealing early chloroquine maculopathy in 27 patients treated for long periods with hydroxychloroquine, which is a less toxic derivative of chloroquine.
Patients and Methods
Twenty-seven patients, ranging in age from 21 to 80 years and suffering from rheumatoid arthritis, systemic lupus erythematosus, familial Mediterranean fever and other col lagen diseases, were examined (Table I) . The subjects were treated with hydroxychloro quine at a dosage of 200 mg.lday for periods ranging from 1 to 9 years.
A second, randomly chosen, group of 28 patients, of similar age, served as a control (Table II) . Some of these subjects suffered from dry eyes or various types of con junctivitis, others were referred for a driving license test. Each patient underwent a full ophthalmo logical examination, including visual acuity, ocular pressure, slit lamp biomicroscopy and direct and indirect fundus ophthalmoscopy, with emphasis on the appearance of the mac ula. Among the treated patients the average intraocular pressure ranged between 14 and 22 mmHg; the anterior segments were normal in all patients except for mild lenticular scle rosis seen in 4 patients, though their visual acuity was maintained at a 6/6-6/12 level. The fundus findings were within normal limits in all these patients, but two patients showed fine pigmentary stippling of the macula and age-related peripheral pigmentary changes.
In the control group six patients aged 58 years and above had mild lenticular sclerosis which affected their visual acuity to the level of 6/12.
Patients with media opacity, ocular or mac ular pathology or any other aetiology which affected their visual acuity, or appeared to affect the CST, were excluded from the study.
The CST was performed using AO contrast sensitivity test plates, with each plate at a test distance of about 57 cm. from the eyes, pro ducing a 2c/degree at plate 2 and up to 6.4c/ degree at plate 7. The test was conducted at the recommended illumination level of 100 ft. candles. After explanation and presentation of the demonstration plate (plate 1) to the patient, each plate was slowly drawn from the original box at a full plate exposure speed of 15 seconds. In elderly patients the plate exposures were repeated twice, in order to recorded on a film, with 110 msec considered the normal first major peak latency.
Results
As shown in Table I , the CST was normal in 15 of the 27 treated patients, suspect in seven patients, and definitely abnormal in five patients-all five having been on antimalarial treatment for periods ranging from one to eight years. The EOG results were normal in 23 out of 27 patients. One patient showed a borderline Arden index (1.7), and the remaining three patients showed definitely pathologic Arden indices, two of these three patients had been on antimalarial medication for two years, and the third for three years. These four patients were also included in the five cases which showed a pathologic CST.
The PVEP was normal in 25 out of 27 patients. In two patients there was a latency of more than 110 msec. In these two cases the EOG was normal, but the CST was suspect. No pathology was discerned which could account for the abnormal PVEP.
In the control group (Table II) , the CST was subnormal in two and borderline in one of the 28 cases. One of the 28 control patients was considered normal though the right eye scored 63, just above the upper limit (62), and the left eye was within the normal range at 60. the EOG was subnormal in only two of the 28 controls. The PVEP was normal in all the controls.
When the two groups were subdivided, using 40 years as the separating age, the treated group was now divided into seven young patients, (subgroup A), and 20 older patients (subgroup B) (see Table I ). The con trol group included ten patients under 40 years of age (subgroup C), and 18 patients over 40 (subgroup D) (see Table II ).
A comparison of these subgroups showed the CST to be subnormal or borderline in three out of seven treated patients in sub group A, and in nine of the 20 patients in subgroup B. In the untreated control patients the results of this test proved normal in all the C control subgroup, and pathologic or border line in three of the 18 in D control subgroup.
On the other hand, normal EOG was seen in all subgroup A patients, and subnormal EOG in four of the 20 subgroup B subjects (Table I ). In the control subgroups (C, D) the EOG was normal in the entire C subgroup, and subnormal in two of the 18 in D control subgroup (Table II) .
The PVEP was subnormal in one patient of each of the A and B treated subgroups, and normal in all the subgroup C and D control patients.
Discussion
Plaque nil maculopathy, which is difficult to detect at the early, occasionally reversible stage, presents a challenge and a major medi colegal problem for ophthalmologists.
In screening for this maculopathy, one of the many tests used is EOG. However, its merits have recently been questioned, with the discovery of low values in untreated patients suffering from rheumatoid arthritis. 15 The CST has been described as a sensitive test for several ocular conditions, including media haziness,16,17 maculopathies,l1 glaucomals and diseases of the optic nerve. 19, 20 Our study of 27 patients treated with hydro xychloroquine for long periods, ranging from one to nine years, showed that it was possible to detect abnormal macular function far more readily by screening these patients with the CST than with either the EOG or PVEP tests. These findings were highly significant as shown by x-square statistical analysis of the three tests, and in a comparison between the control and treated groups.
In the treated patients the CST was patho logic or suspect in 44.4% of the cases (12 out of 27), a significantly high percentage com pared with the 14.8% (four out of 27) found in the EOG test (p<0.02), or the 7.4% (two out of 27) in the PVEP test (p<O.OI).
In the untreated control group, the fre quency of pathologic or suspected CST was 10.7% (three out of 28), as compared with 44.4% in the treated group, the difference between the two groups revealing a high statistical significance (p<0.005).
On the other hand no significant difference in the frequency of pathological changes in the EOG (p<0.99) was found between the con trol group (7.1 %, two out of 28) and the treated group (14.8%).
Since no pathological changes were found in the two subnormal PVEP subjects in the treated group, the results of the test were not considered to be of any significance. It should be emphasised that the abnormal results were detected in fundi of normal appearance.
The reason for the three positive CST cases detected in the control group (Table II) is not clear. In two nuclear sclerosis may be the underlying cause, or in all three just a poor performance. Senile changes in the pigment epithelial cells, such as the accumulation of lipofuscein deposits, might account for the two positive EOG results among the control group.
The findings were more striking on com parison of the treated and untreated sub groups. The EOG proved normal in all the treated A subgroup and control C subgroup, with no difference between the two, whereas the CST was abnormal in 42. 88% (three out of seven) of the treated A subgroup, but normal in the entire matching control C subgroup (p<0.05), statistically very significant. Although significant, the difference was less conspicuous when the older subgroups were considered, with the EOG subnormal in 20% (four out of 20) of the treated B sub group, compared with 11. 1 % (two out of 18) in the control D subgroup (p<0.5). The CST was subnormal in 45% (nine out of 20) of the treated B subgroup, compared with 16.7% (three out of 18) in the control D subgroup (p<O.l).
It should be noted that improvement in the CST performance was evident in patients fol lowing discontinuation of medication, and in some of them the re-establishment of treat ment caused reduction in the CST perform ance (data under evaluation, not included here), a fact which may lend support to the notion that the abnormal results are related to the antimalarial treatment.
Although the group studied was relatively small, the results support the fact that the CST is more effective and sensitive than the EOG in detecting macular hypofunction induced by antimalarial drugs. It should be borne in mind that the CST may show some false positive results with advancing age (Table II) , although in patients under 40 its accuracy is much better. Using this test, macular abnormality was detected in 45% of the treated patients under 40, but none in the control subgroup (p<0.05).
In conclusion, we consider that the CST is a suitable test for evaluation and follow up of chloroquine-induced maculopathy. It is sensi tive, easy to perform and less time consuming than other tests. In addition, although not included in our study, it is less psychologically traumatic for the paediatric age group, which constitutes a considerable proportion of patients under antimalarial treatment.
